27 / 60
27
Scientific programme
Friday, 29 May 2015
P-12
Guided Poster Tour
16:00–17:30
Hall 2 – Poster Area
Pharmacological treatment –adults I
Chair:
M. Rösler, Germany
P-12-001 Predictors of response to atomoxetine
for the treatment of adult patients with
Attention-Deficit/Hyperactivity Disorder
C. Bushe, United Kingdom
E. Sobanski, D. Coghill, L. Berggren, K. De
Bruyckere, S. Leppämäki
P-12-002 Effects of atomoxetine on functional
outcomes, and correlation with the
core symptoms of Attention-Deficit/
Hyperactivity Disorder in adult patients
K. de Bruyckere, Belgium
C. Bushe, C. Bartel, L. Berggren, C. C. Kan,
S. Stes, R. W. Dittmann
P-12-003 Our experience with lisdexamfetamine
dimesylate in Southern Spain
M. A. Fernández Fernández, Spain
M. D. Morillo rojas
P-12-004 Integrated diagnosis and treatment of
adults with Attention-Deficit/Hyperactivity
Disorder (IDEA)
R. Fischer, Germany
M. Rösler, W. Retz
P-12-005 Adult ADHD treated with methylpheni-
date modified-release (MPH-LA) main-
tained functional improvement over a
period of one year
M. Huss, Germany
Y. Ginsberg, T. Arngrim, A. Philipsen,
P. Gandhi, C.-w. Chen, V. Kumar
P-12-006 Long-term safety of methylphenidate
modified-release in adult ADHD upon
continuous exposure up to 66 weeks
M. Huss, Germany
Y. Ginsberg, T. Arngrim, A. Philipsen,
P. Gandhi, C.-w. Chen, V. Kumar
P-13
Guided Poster Tour
16:00–17:30
Hall 2 – Poster Area
Pharmacological treatment –adults II
Chair:
C. B. Surman, USA
P-13-001 Real-world treatment outcomes in adults
with Attention-Deficit/Hyperactivity
Disorder treated with lisdexamfetamine
versus atomoxetine following methylphe-
nidate treatment
A. Joseph, Switzerland
M. Cloutier, A. Guerin, R. Nitulescu, V. Sikirica
P-13-002 Complications in a case of adult ADD:
Bupropion-induced seizure and a MRI-
finding
M. Koelle, Germany
G. Groen, N. Kahn, D. Brummer
P-13-003 Monitoring dose effects of stimulant
medication with AQT processing speed
in adults with ADHD
N. P. Nielsen, Denmark
E. H. Wiig, S. Bäck, G. Ege, J. Gustafsson,
C. Hornborg, G. Magell
P-13-004 Eye movements: Good marker of methyl
phenidate efficiency in ADHD
M. Seassau, France
F. Duval, A. Erb, T. Weiss, R. Carcangiu
P-13-005 Long-term open-label treatment with
atomoxetine in European adult outpa-
tients with Attention-Deficit/Hyperactivity
Disorder
H. Upadhyaya, USA
Y. Tanaka, D. Williams, R. Escobar,
S. Leppämäki
P-13-006 Off-Label use of guanfacine XR in adult
ADHD: A clinical experience
A. Vincent, Canada
P-13-007 Continuity of treatment with methylphe-
nidate in adults with ADHD after seven
years
V. Breda, Brazil
R. Karam, D. Rovaris, F. Picon, M. Victor,
C. Salgado, E. Vitola, N. Mota, K. Silva, P.
Guimaraes-da-Silva, M. Meller, P. Belmonte-
de-Abreu, L. Rohde, E. Grevet, C. Bau